Tan KC - Search Results

1

Increased serum levels of advanced glycation end-products is associated with severity of sleep disordered breathing but not insulin sensitivity in non-diabetic men with obstructive sleep apnoea.

Lam JC, Tan KC, Lai AY, Lam DC, Ip MS. Lam JC, et al. Among authors: tan kc. Sleep Med. 2012 Jan;13(1):15-20. doi: 10.1016/j.sleep.2011.07.015. Epub 2011 Dec 3. Sleep Med. 2012. PMID: 22137116

2

Advanced glycation end products and endothelial dysfunction in type 2 diabetes.

Tan KC, Chow WS, Ai VH, Metz C, Bucala R, Lam KS. Tan KC, et al. Diabetes Care. 2002 Jun;25(6):1055-9. doi: 10.2337/diacare.25.6.1055. Diabetes Care. 2002. PMID: 12032114

3

Association between acute-phase reactants and advanced glycation end products in type 2 diabetes.

Tan KC, Chow WS, Tam S, Bucala R, Betteridge J. Tan KC, et al. Diabetes Care. 2004 Jan;27(1):223-8. doi: 10.2337/diacare.27.1.223. Diabetes Care. 2004. PMID: 14693993

4

HDL dysfunction in obstructive sleep apnea.

Tan KC, Chow WS, Lam JC, Lam B, Wong WK, Tam S, Ip MS. Tan KC, et al. Atherosclerosis. 2006 Feb;184(2):377-82. doi: 10.1016/j.atherosclerosis.2005.04.024. Epub 2005 Jun 21. Atherosclerosis. 2006. PMID: 15975582

5

Advanced glycation endproducts in nondiabetic patients with obstructive sleep apnea.

Tan KC, Chow WS, Lam JC, Lam B, Bucala R, Betteridge J, Ip MS. Tan KC, et al. Sleep. 2006 Mar;29(3):329-33. doi: 10.1093/sleep/29.3.329. Sleep. 2006. PMID: 16553018

6

Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.

Tan KC, Shiu SW, Chow WS, Leng L, Bucala R, Betteridge DJ. Tan KC, et al. Diabetologia. 2006 Nov;49(11):2756-62. doi: 10.1007/s00125-006-0394-1. Epub 2006 Sep 13. Diabetologia. 2006. PMID: 16969649

7

Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetes.

Tan KCB, Chow WS, Tso AWK, Xu A, Tse HF, Hoo RLC, Betteridge DJ, Lam KSL. Tan KCB, et al. Diabetologia. 2007 Sep;50(9):1819-1825. doi: 10.1007/s00125-007-0759-0. Epub 2007 Jul 18. Diabetologia. 2007. PMID: 17639302 Clinical Trial.

8

Increased serum advanced glycation end products are associated with impairment in HDL antioxidative capacity in diabetic nephropathy.

Zhou H, Tan KC, Shiu SW, Wong Y. Zhou H, et al. Among authors: tan kc. Nephrol Dial Transplant. 2008 Mar;23(3):927-33. doi: 10.1093/ndt/gfm631. Epub 2007 Dec 8. Nephrol Dial Transplant. 2008. PMID: 18065800

9

Effects of atorvastatin on serum soluble receptors for advanced glycation end-products in type 2 diabetes.

Tam HL, Shiu SW, Wong Y, Chow WS, Betteridge DJ, Tan KC. Tam HL, et al. Among authors: tan kc. Atherosclerosis. 2010 Mar;209(1):173-7. doi: 10.1016/j.atherosclerosis.2009.08.031. Epub 2009 Aug 21. Atherosclerosis. 2010. PMID: 19733353

10

Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes.

Tam XH, Shiu SW, Leng L, Bucala R, Betteridge DJ, Tan KC. Tam XH, et al. Among authors: tan kc. Clin Sci (Lond). 2011 Jan;120(2):81-9. doi: 10.1042/CS20100256. Clin Sci (Lond). 2011. PMID: 20726839

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

654 results

Search Page

Filters